An updated international consensus on type 2 diabetes management has broadened the focus from glycaemic control alone to the prevention of long-term complications with the help of emerging therapies.

Join online as an expert panel presents their selection of transformational clinical data from the EADV 2026 Annual Congress and discusses the impacts for practice.

US hepatologists have backed carvedilol or variceal ligation for the treatment of high-risk esophageal varices and endorsed an increased focus on vaccinations for patients with cirrhosis as part of a ...

ADHD and autism is particularly prevalent among young people diagnosed with type 2 diabetes before the age of 20, according to data presented at the EASD annual meeting. The analysis used TriNetX US ...

More than one thousand delegates are expected to converge on Auckland’s new conference centre for a highly-anticipated Blood 2026, with a scientific program showcasing the latest innovations across ...